Pantoprazol Accord (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Accord, is a proton pump inhibitor presented as an injection for intravenous use. It treats acid‑related disorders such as gastric ulcer, duodenal ulcer, gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Pantoprazol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pantoprazol Accord is a proton pump inhibitor indicated for conditions that involve excess gastric acid secretion. It helps restore normal gastric pH and promote healing.

- Gastric ulcer: accelerates ulcer healing and reduces recurrence risk. - Duodenal ulcer: promotes mucosal repair and symptom relief. - Gastro‑oesophageal reflux disease: decreases reflux episodes and heartburn. - Erosive esophagitis: facilitates healing of erosive lesions. - Zolligan‑Ellison syndrome: controls acid hypersecretion associated with gastrin‑producing tumors.

Pantoprazol Accord may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Dizziness

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Acute interstitial nephritis - Hepatotoxicity - Low magnesium levels (hypomagnesemia) - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When using Pantoprazol Accord, clinicians should consider several safety aspects.

- Renal impairment: adjust use in patients with severe kidney dysfunction. - Hepatic impairment: monitor liver function in patients with existing liver disease. - Elderly patients: observe for increased sensitivity to adverse effects. - Concomitant use with drugs that require gastric acidity for absorption: assess need for alternative therapy. - Pregnancy and lactation: prescribe only if the potential benefit outweighs potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Pantoprazol Accord can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiretroviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: slight increase in serum levels. - Methotrexate: reduced clearance at high doses. - Iron supplements: decreased iron absorption. - Diazepam: modest increase in plasma concentration.